These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 12793576)

  • 1. A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement.
    Hidalgo-Ovejero AM; Garcia-Mata S; Martinez-Grande M; Otermin-Maya I
    J Bone Joint Surg Br; 2003 May; 85(4):619-20; author reply 620. PubMed ID: 12793576
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of deep vein thrombosis in knee arthroplasty. Preliminary results from a randomized controlled study of low molecular weight heparin vs foot pump compression.
    Norgren L; Toksvig-Larsen S; Magyar G; Lindstrand A; Albrechtsson U
    Int Angiol; 1998 Jun; 17(2):93-6. PubMed ID: 9754896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement.
    Warwick D; Harrison J; Whitehouse S; Mitchelmore A; Thornton M
    J Bone Joint Surg Br; 2002 Apr; 84(3):344-50. PubMed ID: 12002490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin.
    Gelfer Y; Tavor H; Oron A; Peer A; Halperin N; Robinson D
    J Arthroplasty; 2006 Feb; 21(2):206-14. PubMed ID: 16520208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of enoxaparin in the treatment of deep vein thrombosis.
    Deitcher SR
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1026-33. PubMed ID: 11484302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.
    Westrich GH; Bottner F; Windsor RE; Laskin RS; Haas SB; Sculco TP
    J Arthroplasty; 2006 Sep; 21(6 Suppl 2):139-43. PubMed ID: 16950076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative heparin in addition to postoperative low-molecular-weight heparin for thromboprophylaxis in total knee replacement.
    Mant MJ; Russell DB; Johnston DW; Donahue PA
    J Bone Joint Surg Br; 2000 Jan; 82(1):48-9. PubMed ID: 10697313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump.
    Santori FS; Vitullo A; Stopponi M; Santori N; Ghera S
    J Bone Joint Surg Br; 1994 Jul; 76(4):579-83. PubMed ID: 8027144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of deep vein thrombosis in non-surgical patients].
    Kröger K
    Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1706-10. PubMed ID: 16003608
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    Eriksson BI; Wille-Jørgensen P; Kälebo P; Mouret P; Rosencher N; Bösch P; Baur M; Ekman S; Bach D; Lindbratt S; Close P
    N Engl J Med; 1997 Nov; 337(19):1329-35. PubMed ID: 9358126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of deep vein thrombosis in total knee replacement--current status of therapy in orthopedie and trauma departments in Germany].
    Lüring C; Oczipka F; Bäthis H; Grifka J; Tingart M
    Sportverletz Sportschaden; 2006 Sep; 20(3):149-52. PubMed ID: 16998769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
    Ettema HB; Hoppener MR; Büller HR; Henny ChP; Verheyen CC
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1842-7. PubMed ID: 14533495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.